UK-based pharmaceutical company 4D pharma plc (AIM: DDDD) has filed a registration statement on form F-4 with the US Securities and Exchange Commission, the company said.
The filing follows the announcement on October 22, 2020 of the proposed merger between 4D pharma and Longevity acquisition Corp. (NASDAQ: LOAC), a NASDAQ-listed Special Purpose acquisition company.
Avista Capital Partners Closes Acquisition of Solmetex
H.I.G. Capital Acquires Battery Distributor Continental Batteries
Peck Company Holdings Closes Acquisition of iSun Energy, Changes Name to iSun
Helios Technologies Acquires Engineering Solutions Firm BJN Technologies
Generational Equity Advises Rehagen Electrical Contracting in Sale to MidStates Energy
Altius Resources Ups Stake in Wolfden Resources
Tracker Capital Acquires Controlling Interest in Presage Security
National Convenience Distributors Acquires Wholesale Distributor Wustefeld Candy
Upland Software Acquires Second Street for USD 25.4m
Terreno Realty Acquires New Jersey Industrial Property for USD 10.6m
Skyward Specialty Insurance Group Acquires Aegis Surety from K2 Insurance Services
Cadence to Acquire NUMECA to Expand System Analysis Capabilities
Turnstone Biologics Acquires Myst Therapeutics to Expand Biotechnology Portfolio
Bolt Acquires Assets of Last Mile Holdings to Expand Micromobility Solutions in US